MedCity News January 16, 2025
Arundhati Parmar

Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for the worse if the incoming Trump administration veered away from accepted norms regarding vaccines.

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco on Monday regarding the controversial positions that Robert F. Kennedy Jr. has taken on vaccines. Kennedy is President-elect Donald Trump’s nominee to lead the Department of Health and Human Services but needs to be confirmed by the Senate.

Bourla, whose company is synonymous with the Covid vaccines in the mainstream American consciousness, was asked by Chris Schott, a J.P. Morgan analyst, about...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Patients, clinics grapple with unintended consequence of lower drug prices
Prescription drug cap may save Medicare enrollees thousands: Report
UnitedHealth Group CEO: Value-Based Care Could Offset Rising Provider, Drug Costs
Hive Mentality: Is Behavior Programmed Into DNA?
JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

Share This Article